Perceptive Advisors LLC Uro Gen Pharma Ltd. Transaction History

Perceptive Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$38.64 - $57.54 $7.69 Million - $11.5 Million	-199,014 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$27.28 - $43.26 $1.91 Million - $3.03 Million	-70,000 Reduced 26.02%	199,014 $7.41 Million
Q3 2017 Nov 14, 2017	BUY	$17.15 - $32.72 $4.61 Million - $8.8 Million	269,014	269,014 $8.48 Million

113

24M

46.9K

44.3K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $373M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.